|
ZA836080B
(en)
*
|
1982-08-23 |
1984-04-25 |
Scripps Clinic Res |
Broad spectrum influenza antisera
|
|
US5182192A
(en)
|
1987-03-27 |
1993-01-26 |
The Wistar Institute |
Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
FR2664905B1
(fr)
|
1990-07-18 |
1994-08-12 |
Agronomique Inst Nat Rech |
Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus.
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
ES2108048T3
(es)
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ATE463573T1
(de)
|
1991-12-02 |
2010-04-15 |
Medimmune Ltd |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
US6337070B1
(en)
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
|
EP0621339B1
(en)
|
1992-09-17 |
2001-10-24 |
Takara Shuzo Co. Ltd. |
Immunogenic human influenza A virus haemagglutinin polypeptides
|
|
JP3037554B2
(ja)
|
1993-04-20 |
2000-04-24 |
寳酒造株式会社 |
免疫原性人工ポリペプチド
|
|
US5589174A
(en)
|
1992-09-17 |
1996-12-31 |
Takara Shuzo Co., Ltd. |
Anti-human influenza virus antibody
|
|
GB9221654D0
(en)
|
1992-10-15 |
1992-11-25 |
Scotgen Ltd |
Recombinant human anti-cytomegalovirus antibodies
|
|
WO1994016109A1
(en)
*
|
1993-01-15 |
1994-07-21 |
Whitehead Institute For Biomedical Research |
Membrane fusion events and means for altering same
|
|
WO1994017826A1
(en)
|
1993-02-01 |
1994-08-18 |
Smithkline Beecham Corporation |
Vaccinal polypeptides
|
|
US5573916A
(en)
*
|
1994-05-19 |
1996-11-12 |
Coretech, Inc. |
Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
|
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
EP0822830B1
(en)
|
1995-04-27 |
2008-04-02 |
Amgen Fremont Inc. |
Human anti-IL-8 antibodies, derived from immunized xenomice
|
|
CA2219486A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
EP2305027B1
(en)
|
1996-12-03 |
2014-07-02 |
Amgen Fremont Inc. |
Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
|
|
US6165476A
(en)
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
|
AU4134000A
(en)
|
1999-04-29 |
2000-11-17 |
Syngenta Limited |
Herbicide resistant plants
|
|
AR025750A1
(es)
*
|
1999-09-24 |
2002-12-11 |
Smithkline Beecham Biolog |
Vacunas
|
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
CN100489107C
(zh)
*
|
2000-04-28 |
2009-05-20 |
圣朱德儿童研究医院 |
用于产生感染性流感病毒的dna转染系统
|
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
|
EP3009507B1
(en)
|
2002-02-13 |
2020-06-24 |
Wisconsin Alumini Research Foundation |
Signal for packaging of influenza virus vectors
|
|
US20040091503A1
(en)
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
WO2004067553A2
(en)
|
2003-01-29 |
2004-08-12 |
The Research Foundation Of The State University Of New York |
Tolerance-induced targeted antibody production
|
|
JP4675317B2
(ja)
*
|
2003-01-30 |
2011-04-20 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
アジュバント化インフルエンザワクチン
|
|
JP4368594B2
(ja)
|
2003-02-24 |
2009-11-18 |
株式会社インシリコサイエンス |
タンパク質構造予測装置、タンパク質構造予測方法、プログラム、および、記録媒体
|
|
CN100393870C
(zh)
|
2003-05-05 |
2008-06-11 |
波依斯汤普森植物研究所 |
用于制备免疫保护性组合物的载体和来源于转基因植物的细胞
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
DK2261376T3
(da)
*
|
2003-11-04 |
2013-10-07 |
Univ Tulane |
Fremgangsmåde til hindring af virus:celle-fusion ved hæmning af funktionen af fusionsinitieringsregionen i RNA vira med klasse I membranfusogene indhyldningsproteiner
|
|
EP1766059B1
(en)
*
|
2004-05-25 |
2012-07-11 |
MedImmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
|
CA2598884A1
(en)
*
|
2005-02-24 |
2006-10-05 |
University Of Massachusetts |
Influenza nucleic acids, polypeptides, and uses thereof
|
|
EP1885186B1
(en)
|
2005-06-01 |
2015-09-02 |
California Institute Of Technology |
Method of targeted gene delivery using viral vectors
|
|
JP4758148B2
(ja)
|
2005-06-14 |
2011-08-24 |
泰三 宇田 |
インフルエンザウイルスのヘマグルチニンに対する抗体酵素
|
|
PL1951299T3
(pl)
*
|
2005-11-04 |
2012-07-31 |
Novartis Ag |
Szczepionki przeciw grypie zawierające kombinacje adiuwantów cząsteczkowych i czynników wzmacniających immunogenność
|
|
EP2251034B1
(en)
|
2005-12-02 |
2018-02-14 |
Icahn School of Medicine at Mount Sinai |
Chimeric newcastle disease viruses presenting non-native surface proteins and uses thereof
|
|
ES2385842T3
(es)
*
|
2005-12-06 |
2012-08-01 |
Yeda Research And Development Co., Ltd. |
Vacuna mejorada contra la gripe
|
|
US10183986B2
(en)
*
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
|
EP3011969A1
(en)
|
2006-03-07 |
2016-04-27 |
Vaxinnate Corporation |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
|
US8148085B2
(en)
|
2006-05-15 |
2012-04-03 |
Sea Lane Biotechnologies, Llc |
Donor specific antibody libraries
|
|
WO2007134327A2
(en)
|
2006-05-15 |
2007-11-22 |
Sea Lane Biotechnologies, Llc. |
Neutralizing antibodies to influenza viruses
|
|
WO2008054540A2
(en)
*
|
2006-05-18 |
2008-05-08 |
Pharmexa Inc. |
Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
|
|
WO2008005777A2
(en)
|
2006-06-30 |
2008-01-10 |
Novavax, Inc. |
Methods of enhancing protein incorporation into virus like particles
|
|
AU2007275010B2
(en)
|
2006-07-21 |
2013-06-20 |
California Institute Of Technology |
Targeted gene delivery for dendritic cell vaccination
|
|
CA2663388C
(en)
|
2006-09-07 |
2017-01-17 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
|
|
WO2008032219A2
(en)
|
2006-09-11 |
2008-03-20 |
Novartis Ag |
Making influenza virus vaccines without using eggs
|
|
CN101607995B
(zh)
*
|
2007-06-15 |
2013-05-01 |
厦门大学 |
特异性结合h5亚型禽流感病毒血凝素蛋白的单克隆抗体或其结合活性片段及其用途
|
|
EP2014279A1
(en)
*
|
2007-06-22 |
2009-01-14 |
Pevion Biotech AG |
Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
|
|
CA2615372A1
(en)
|
2007-07-13 |
2009-01-13 |
Marc-Andre D'aoust |
Influenza virus-like particles (vlps) comprising hemagglutinin
|
|
US20090092635A1
(en)
|
2007-08-17 |
2009-04-09 |
Wyeth |
Heterologous prime-boost immunization regimen
|
|
EP2200639B1
(en)
*
|
2007-09-24 |
2016-03-30 |
Government of the USA, as Represented by the Secretary, Department of Health and Human Services |
Immunostimulatory combinations of tlr3 ligands with tlr2 and tlr9 agonists and methods of use
|
|
FR2921387B1
(fr)
|
2007-09-26 |
2012-04-20 |
Sanofi Pasteur |
Procede de production du virus de la grippe
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
PT2610345E
(pt)
|
2007-11-27 |
2016-01-11 |
Medicago Inc |
Partículas semelhantes ao vírus (vlps) da gripe recombinantes produzidas em plantas transgénicas que expressam hemaglutinina
|
|
MX2010006148A
(es)
|
2007-12-06 |
2011-02-23 |
Dana Farber Cancer Inst Inc |
Anti-cuerpos contra el virus de la influenza y metodos de uso de los mismos.
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
WO2009121004A2
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to viral antigens
|
|
GB0905570D0
(en)
|
2009-03-31 |
2009-05-13 |
Novartis Ag |
Combined vaccines
|
|
ES2524553T3
(es)
*
|
2008-06-17 |
2014-12-10 |
Apogenix Gmbh |
Receptores multiméricos de TNF
|
|
EA019138B1
(ru)
*
|
2008-06-25 |
2014-01-30 |
Инсэрм (Инститют Насиональ Де Ля Сантэ Э Де Ля Решерш Медикаль) |
Новые иммуноадъювантные соединения на основе флагеллина и их применение
|
|
EP2294202B1
(en)
|
2008-07-08 |
2015-05-20 |
Medicago Inc. |
Soluble recombinant influenza antigens
|
|
CA2787099A1
(en)
|
2009-03-30 |
2010-10-14 |
Anice C. Lowen |
Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
|
|
WO2010130636A1
(en)
|
2009-05-11 |
2010-11-18 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
|
AU2010254136B2
(en)
*
|
2009-05-26 |
2016-09-29 |
Mount Sinai School Of Medicine |
Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
|
|
JP5871796B2
(ja)
|
2009-06-24 |
2016-03-01 |
メディカゴ インコーポレイテッド |
ヘマグルチニンを含むキメラインフルエンザウイルス様粒子
|
|
CA2805505C
(en)
*
|
2009-07-30 |
2021-08-03 |
Mount Sinai School Of Medecine |
Chimeric influenza viruses having reduced ability to reassort with other influenza viruses and uses thereof
|
|
JP5463107B2
(ja)
|
2009-09-14 |
2014-04-09 |
独立行政法人国立国際医療研究センター |
新型インフルエンザを特異的に鑑別するモノクローナル抗体とそれを利用した免疫検出試薬
|
|
JP2013060367A
(ja)
|
2010-01-15 |
2013-04-04 |
Osaka Univ |
抗インフルエンザ抗体及びインフルエンザ検出用デバイス
|
|
US8298820B2
(en)
*
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
|
US9701723B2
(en)
|
2010-02-18 |
2017-07-11 |
Icahn School Of Medicine At Mount Sinai |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
|
US9573991B2
(en)
|
2010-03-08 |
2017-02-21 |
Celltrion, Inc. |
Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses
|
|
CN102939103A
(zh)
*
|
2010-03-30 |
2013-02-20 |
西奈山医学院 |
流感病毒疫苗及其应用
|
|
EP2596017B1
(en)
|
2010-07-22 |
2019-04-03 |
John W. Schrader |
Cross-protective antibody against influenza viral infection
|
|
KR20140068205A
(ko)
|
2011-09-20 |
2014-06-05 |
마운트 시나이 스쿨 오브 메디슨 |
인플루엔자 바이러스 백신 및 이의 용도
|
|
MY170927A
(en)
|
2011-11-28 |
2019-09-19 |
Janssen Vaccines & Prevention Bv |
Influenza virus vaccines and uses thereof
|
|
CA2894506C
(en)
|
2012-12-11 |
2021-08-10 |
Vib Vzw |
Anti-influenza antibody
|
|
KR20150104117A
(ko)
|
2012-12-18 |
2015-09-14 |
이칸 스쿨 오브 메디슨 엣 마운트 시나이 |
인플루엔자 바이러스 백신 및 그의 용도
|